Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Dick-Johan van Spronsen"'
Autor:
Eline Bouwman, Iridi Stollman, Joyce Wilbers, Joyce J. M. Claessens, Dick Johan van Spronsen, Annet Bongaerts, Dionne Breij, Nicole M. A. Blijlevens, Hans Knoop, Rosella P. M. G. Hermens, Jacqueline J. Loonen
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-19 (2024)
Abstract Background Childhood, adolescent, and young adult (CAYA) cancer survivors, at risk for late effects, including cancer-related fatigue, cardiovascular issues, and psychosocial challenges, may benefit from interventions stimulating behaviour a
Externí odkaz:
https://doaj.org/article/ff6d7550253143c7b7196fc11eb09995
Autor:
Adinda Mieras, Annelies Nijdam, Berthe M. P. Aleman, Laurien Daniels, Eva De Jongh, Cécile P.M. Janus, Stijn Krol, Bastiaan D.P. Ta, Francisca Ong, Dick Johan Van Spronsen, Ward Posthuma, Wouter J. Plattel, Rimke Oostvogels, Karijn Verschueren, Josée. M. Zijlstra, Flora E. Van Leeuwen
Publikováno v:
HemaSphere, Vol 6, Pp 36-37 (2022)
Externí odkaz:
https://doaj.org/article/a6bd26d1d1a14604b3c466325b58bc48
Autor:
Alessandro Leal, Nicole C. T. van Grieken, Doreen N. Palsgrove, Jillian Phallen, Jamie E. Medina, Carolyn Hruban, Mark A. M. Broeckaert, Valsamo Anagnostou, Vilmos Adleff, Daniel C. Bruhm, Jenna V. Canzoniero, Jacob Fiksel, Marianne Nordsmark, Fabienne A. R. M. Warmerdam, Henk M. W. Verheul, Dick Johan van Spronsen, Laurens V. Beerepoot, Maud M. Geenen, Johanneke E. A. Portielje, Edwin P. M. Jansen, Johanna van Sandick, Elma Meershoek-Klein Kranenbarg, Hanneke W. M. van Laarhoven, Donald L. van der Peet, Cornelis J. H. van de Velde, Marcel Verheij, Remond Fijneman, Robert B. Scharpf, Gerrit A. Meijer, Annemieke Cats, Victor E. Velculescu
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
Identifying patients that will respond to a particular therapy remains a key challenge in precision oncology. Here, in gastric cancer, the authors show that circulating tumour DNA can predict recurrence, provided that the signal from white blood cell
Externí odkaz:
https://doaj.org/article/e873283671f243d3ba192161c80d36a7
Autor:
Yvonne Koop, Laura Dobbe, Angela H E M Maas, Dick Johan van Spronsen, Femke Atsma, Saloua El Messaoudi, Hester Vermeulen
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0249067 (2021)
Breast cancer (BC) patients have an increased risk of developing cancer therapy-related cardiac dysfunction (CTRCD) and cardiovascular morbidity, which seems to have a substantial prognostic impact. Oncologists, in collaboration with dedicated cardio
Externí odkaz:
https://doaj.org/article/223c98dbe0cc413390b75e67a2a8c459
Autor:
Simone de Vries, Miriam L. Haaksma, Katarzyna Jóźwiak, Michael Schaapveld, David C. Hodgson, Pieternella J. Lugtenburg, Augustinus D.G. Krol, Eefke J. Petersen, Dick Johan van Spronsen, Sameera Ahmed, Michael Hauptmann, Berthe M.P. Aleman, Flora E. van Leeuwen
Publikováno v:
Journal of Clinical Oncology, 41, 1, pp. 86-95
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(1), 86-95. American Society of Clinical Oncology
Journal of Clinical Oncology, 41, 86-95
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(1), 86-95. American Society of Clinical Oncology
Journal of Clinical Oncology, 41, 86-95
PURPOSE Previous efforts to predict absolute risk of treatment-related cardiovascular diseases (CVDs) have mostly focused on childhood cancer survivors. We aimed to develop prediction models for risk of coronary heart disease (CHD) and heart failure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::769bdb79a428458b676f89cd6902a921
https://repository.ubn.ru.nl/handle/2066/289461
https://repository.ubn.ru.nl/handle/2066/289461
Autor:
Suraya Elfrink, Martin ter Beest, Luuk Janssen, Marijke P. Baltissen, Pascal W. T. C. Jansen, Angelique N. Kenyon, Raymond M. Steen, Daynelys de Windt, Philipp M. Hagemann, Corine Hess, Dick-Johan van Spronsen, Brigiet Hoevenaars, Ellen van der Spek, Zijun Y. Xu-Monette, Ken H. Young, Charlotte Kaffa, Sander Bervoets, Jolien van Heek, Eva Hesius, Charlotte M. de Winde, Michiel Vermeulen, Michiel van den Brand, Blanca Scheijen, Annemiek B. van Spriel
Publikováno v:
BLOOD ADVANCES, 6(7), 2254-2266. American Society of Hematology
Blood Advances, 6, 2254-2266
Elfrink, S, ter Beest, M, Janssen, L, Baltissen, M P, Jansen, P W T C, Kenyon, A N, Steen, R M, de Windt, D, Hagemann, P M, Hess, C, van Spronsen, D J, Hoevenaars, B, van der Spek, E, Xu-Monette, Z Y, Young, K H, Kaffa, C, Bervoets, S, van Heek, J, Hesius, E, de Winde, C M, Vermeulen, M, van den Brand, M, Scheijen, B & van Spriel, A B 2022, ' IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma ', BLOOD ADVANCES, vol. 6, no. 7, pp. 2254-2266 . https://doi.org/10.1182/bloodadvances.2021004366
Blood Advances, 6, 7, pp. 2254-2266
Blood Advances, 6, 2254-2266
Elfrink, S, ter Beest, M, Janssen, L, Baltissen, M P, Jansen, P W T C, Kenyon, A N, Steen, R M, de Windt, D, Hagemann, P M, Hess, C, van Spronsen, D J, Hoevenaars, B, van der Spek, E, Xu-Monette, Z Y, Young, K H, Kaffa, C, Bervoets, S, van Heek, J, Hesius, E, de Winde, C M, Vermeulen, M, van den Brand, M, Scheijen, B & van Spriel, A B 2022, ' IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma ', BLOOD ADVANCES, vol. 6, no. 7, pp. 2254-2266 . https://doi.org/10.1182/bloodadvances.2021004366
Blood Advances, 6, 7, pp. 2254-2266
Contains fulltext : 248786.pdf (Publisher’s version ) (Open Access) Diffuse large B-cell lymphoma (DLBCL) represents the most common form of non-Hodgkin lymphoma (NHL) that is still incurable in a large fraction of patients. Tetraspanin CD37 is hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c9362c02409474953d468c7bfab5331
https://research.vumc.nl/en/publications/c5927e2c-91d7-4654-8eb4-2172d145dada
https://research.vumc.nl/en/publications/c5927e2c-91d7-4654-8eb4-2172d145dada
Autor:
Yvonne Koop, Arco J. Teske, Iris Wanders, Hanneke Meijer, J. H. A. M. Kaanders, Olivier C. Manintveld, H. Carlijne Hassing, Hester Vermeulen, Angela H. E. M. Maas, Dick-Johan van Spronsen, Femke Atsma, Saloua El Messaoudi
Publikováno v:
Journal of Cancer Survivorship, 17, 4, pp. 1131-1138
Journal of Cancer Survivorship, 17. Springer New York
Journal of Cancer Survivorship, 17. Springer New York
Background The awareness of cancer therapy–related adverse cardiac effects is fueled by recent literature on cardiotoxicity incidence and detection strategies. Although this influences the sense of urgency, in current practice, cardiotoxicity monit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d296a63371b1b76a0cf240214dd71b2
https://pubmed.ncbi.nlm.nih.gov/35118579
https://pubmed.ncbi.nlm.nih.gov/35118579
Autor:
Jacobien M. Kieffer, Sonia Ancoli-Israel, Margreet Houmes, Eva de Jongh, Jessie L. de Geus, Huub H. van Rossum, Dick Johan van Spronsen, Heiddis B. Valdimarsdottir, Daniëlle E. J. Starreveld, Flora E. van Leeuwen, Eus J.W. Van Someren, Jos A. Bosch, Eveline M. A. Bleiker, Susan K. Lutgendorf, Erik W.A. Marijt, Cecile P.M. Janus, Mirthe Lanfermeijer, Catharina M. Korse, L. Daniels, Marie José Kersten, Lara H Böhmer, Roel J. de Weijer, Josee M. Zijlstra, William H. Redd, G. Esther A. Habers
Publikováno v:
Cancers, 13(19):4948. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 13(19). MDPI
Cancers
Cancers, 13, 19
Starreveld, D E J, Daniels, L A, Kieffer, J M, Valdimarsdottir, H B, de Geus, J, Lanfermeijer, M, van Someren, E J W, Habers, G E A, Bosch, J A, Janus, C P M, van Spronsen, D J, de Weijer, R J, Marijt, E W A, de Jongh, E, Zijlstra, J M, Böhmer, L H, Houmes, M, Kersten, M J, Korse, C M, van Rossum, H H, Redd, W H, Lutgendorf, S K, Ancoli-israel, S, van Leeuwen, F E & Bleiker, E M A 2021, ' Light therapy for cancer-related fatigue in (Non-)hodgkin lymphoma survivors : Results of a randomized controlled trial ', Cancers, vol. 13, no. 19, 4948 . https://doi.org/10.3390/cancers13194948
Cancers, Vol 13, Iss 4948, p 4948 (2021)
Cancers, 13
Cancers, vol 13, iss 19
Cancers; Volume 13; Issue 19; Pages: 4948
Cancers, 13(19):4948. MDPI Multidisciplinary Digital Publishing Institute
Cancers, 13(19). MDPI
Cancers
Cancers, 13, 19
Starreveld, D E J, Daniels, L A, Kieffer, J M, Valdimarsdottir, H B, de Geus, J, Lanfermeijer, M, van Someren, E J W, Habers, G E A, Bosch, J A, Janus, C P M, van Spronsen, D J, de Weijer, R J, Marijt, E W A, de Jongh, E, Zijlstra, J M, Böhmer, L H, Houmes, M, Kersten, M J, Korse, C M, van Rossum, H H, Redd, W H, Lutgendorf, S K, Ancoli-israel, S, van Leeuwen, F E & Bleiker, E M A 2021, ' Light therapy for cancer-related fatigue in (Non-)hodgkin lymphoma survivors : Results of a randomized controlled trial ', Cancers, vol. 13, no. 19, 4948 . https://doi.org/10.3390/cancers13194948
Cancers, Vol 13, Iss 4948, p 4948 (2021)
Cancers, 13
Cancers, vol 13, iss 19
Cancers; Volume 13; Issue 19; Pages: 4948
Cancers, 13(19):4948. MDPI Multidisciplinary Digital Publishing Institute
Simple SummaryCancer-related fatigue (CRF) is one of the most frequently reported symptoms with prevalence rates of 25 to 60 percent in (non-)Hodgkin lymphoma survivors. Several (pilot) studies showed promising effects of light therapy to reduce CRF.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b7ef0f9788a03eb260e3b273e6b4372
https://hdl.handle.net/1887/3270923
https://hdl.handle.net/1887/3270923
Autor:
Linda Heijmen, Edwin E G W ter Voert, Wim J G Oyen, Cornelis J A Punt, Dick Johan van Spronsen, Arend Heerschap, Lioe-Fee de Geus-Oei, Hanneke W M van Laarhoven
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0120823 (2015)
AimAim of this study was to investigate the potential of 18F-FDG PET, diffusion weighted imaging (DWI) and susceptibility-weighted (T2*) MRI to predict response to systemic treatment in patients with colorectal liver metastases. The predictive values
Externí odkaz:
https://doaj.org/article/9d87fb9fd8564017b4548c7d24d4bde4
Autor:
Saskia A.M. van de Schans, Liza N. van Steenbergen, Jan Willem W. Coebergh, Maryska L.G. Janssen-Heijnen, Dick Johan van Spronsen
Publikováno v:
Haematologica, Vol 99, Iss 2 (2014)
Survival rates determined at diagnosis are often too negative for cancer survivors. Conditional relative survival reflects actual prognosis during follow-up better. Data from all 54,015 patients newly diagnosed in the Netherlands with B-cell non-Hodg
Externí odkaz:
https://doaj.org/article/aa1b7ded58414e7688d85b1cbb033e43